United States
Germany
Japan
United Kingdom
China
KRAS mutant (G12A), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12A |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KRAS mutant (Q61R), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | Q61R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KRAS - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
KRAS mutant (Q61H), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | Q61H |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (Q61L), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | Q61L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13C), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13S), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13S |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13R), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13A), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13A |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (A146T), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | A146T |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G12F), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12F |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Expression Hosts
Lentivirus
Tags
Vectors
QC Levels
Families
Pathways
- Acute myeloid leukemia (55)
- Axon guidance (55)
- B cell receptor signaling pathway (55)
- Bladder cancer (55)
- Chemokine signaling pathway (55)
- Chronic myeloid leukemia (55)
- Colorectal cancer (55)
- Dorso-ventral axis formation (55)
- Endometrial cancer (55)
- ErbB signaling pathway (55)
- Fc epsilon RI signaling pathway (55)
- Gap junction (55)
- Glioma (55)
- GnRH signaling pathway (55)
- Insulin signaling pathway (55)
- Long-term depression (55)
- Long-term potentiation (55)
- MAPK signaling pathway (55)
- Melanogenesis (55)
- Melanoma (55)
- Natural killer cell mediated cytotoxicity (55)
- Neurotrophin signaling pathway (55)
- Non-small cell lung cancer (55)
- Pancreatic cancer (55)
- Pathways in cancer (55)
- Progesterone-mediated oocyte maturation (55)
- Prostate cancer (55)
- Regulation of actin cytoskeleton (55)
- Renal cell carcinoma (55)
- T cell receptor signaling pathway (55)
- Thyroid cancer (55)
- Tight junction (55)
- VEGF signaling pathway (55)
